Sector ratings Perspective Therapeutics, Inc.
Stocks
CATX
US46489V3024
Biotechnology & Medical Research
|
Real-time Estimate
Cboe BZX
10:50:14 18/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 2.845 USD | -1.22% |
|
+2.31% | +4.55% |
| 19/08 | BMO Capital Initiates Perspective Therapeutics at Outperform | MT |
| 14/08 | BofA Securities Adjusts Perspective Therapeutics Price Target to $5 From $6 | MT |
Main competitors
| Capi.($) | Investor | ESG MSCI | Fundamentals | Financial revisions | Global Valuation | Visibility | Consensus | ||
|---|---|---|---|---|---|---|---|---|---|
 | 33Cr | - | BBB | - | - | ||||
| 4.62TCr | AAA | |||||||
| 4.43TCr | AAA | |||||||
| 4.22TCr | - | B | - | - | ||||
| 4.02TCr | - | |||||||
| 2.98TCr | A | |||||||
| 1.72TCr | BBB | |||||||
| 1.57TCr | - | - | - | - | ||||
| 1.53TCr | AA | |||||||
| 1.31TCr | AAA | |||||||
| 1.34TCr | AA | |||||||
| 1.45TCr | A | - | ||||||
| 1.14TCr | AA | |||||||
| 1.1TCr | AA | |||||||
| 985.17Cr | - | BBB | - | - | ||||
| 929.86Cr | BB | - | ||||||
| 937.65Cr | - | BBB | - | - | ||||
| 1.08TCr | AA | - | ||||||
| 917.78Cr | AAA | |||||||
| 866.83Cr | - | B | - | - | ||||
| Average | 1.86TCr | AA | |||||||
| Weighted average by Cap. | AA |
Select your edition
All financial news and data tailored to specific country editions
